Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Thursday, October 22, 2020  Spokane, Washington  Est. May 19, 1883
Clear Day 46° Clear

Tag search results

Tags let us describe our content with keywords, making it easier to find what you're most interested in. Use the search box to look for tags, or explore our coverage with the lists below.

FDA discloses vaccine guidelines blocked by White House

The Food and Drug Administration laid out updated safety standards Tuesday for makers of COVID-19 vaccines after the White House blocked their formal release, the latest political tug-of-war between the Trump administration and the government’s public health scientists.

Second Trump appointee out at FDA amid credibility concerns

A second Trump administration appointee has been ousted at the Food and Drug Administration in the wake of the agency's botched announcement about an experimental therapy for COVID-19, which medical experts said damaged the health regulator's credibility with the public.

Health agencies’ credibility at risk after week of blunders

The credibility of two of the nation’s leading public health agencies is under fire this week after controversial decisions that outside experts say smack of political pressure from President Donald Trump as he attempts to move past the devastating toll of the coronavirus ahead of the November election.

FDA chief apologizes for overstating plasma effect on virus

Responding to an outcry from medical experts, Food and Drug Administration Commissioner Stephen Hahn on Tuesday apologized for overstating the life-saving benefits of treating COVID-19 patients with convalescent plasma.

UN cautions that virus plasma treatment still experimental

The World Health Organization on Monday cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy, voicing the concern as a U.S. boost for the treatment has many scientists afraid formal studies will be derailed.

US revokes emergency use of malaria drugs vs. coronavirus

U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects.

FDA wants heartburn meds off the market due to contamination

U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought.

Sales of most e-cigarette pod flavors to end in 30 days

The Food and Drug Administration on Thursday ordered companies to stop manufacturing, distributing and selling most cartridge-based e-cigarette flavors by early February, saying the crackdown is urgently needed to reduce teen vaping.

Trump suggests some flavored vapes may be pulled from market

President Donald Trump says the federal government will soon announce a new strategy to tackle underage vaping, promising, “We’re going to protect our families, we’re going to protect our children, and we’re going to protect the industry.”

U.S. finds contaminant in popular heartburn drug

WASHINGTON – U.S. health officials are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related drugs. For now, the Food and Drug Administration said patients can continue taking their medications.